Tubal ligation frequency in Oklahoma women with cervical cancer.

[1]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[2]  E. Stanbridge,et al.  Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: A Gynecologic Oncology Group study in United States , 2009, International journal of cancer.

[3]  S. Wacholder,et al.  Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma , 2009, International journal of cancer.

[4]  S. Wacholder,et al.  Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants , 2009, Cancer Epidemiology Biomarkers & Prevention.

[5]  S. Coughlin,et al.  Burden of cervical cancer in the United States, 1998–2003 , 2008, Cancer.

[6]  Joakim Dillner,et al.  Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study , 2008, BMJ : British Medical Journal.

[7]  Charlotte Paul,et al.  Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. , 2008, The Lancet. Oncology.

[8]  V. Beral,et al.  Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies , 2007, The Lancet.

[9]  Joakim Dillner,et al.  Human papillomavirus and Papanicolaou tests to screen for cervical cancer. , 2007, The New England journal of medicine.

[10]  Stephen D Walter,et al.  Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. , 2007, The New England journal of medicine.

[11]  T. Wright,et al.  2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests , 2007, Journal of lower genital tract disease.

[12]  G. Flannelly,et al.  Cervical screening history in patients with early stage carcinoma of the cervix. , 2006, Irish medical journal.

[13]  M. Nygård,et al.  Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program , 2005, Cancer Causes & Control.

[14]  S. Ciatto,et al.  Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case–control study in Florence , 2004, British Journal of Cancer.

[15]  M. Sherman,et al.  Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000 , 2004, Cancer.

[16]  R. Ray,et al.  Risk factors for progression of squamous cell cervical carcinoma in-situ to invasive cervical cancer: results of a multinational study , 2002, Cancer Causes & Control.

[17]  J. T. Cox,et al.  2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. , 2003, Journal of lower genital tract disease.

[18]  N. Kiviat,et al.  Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. , 2001, American journal of epidemiology.

[19]  M. Sherman,et al.  Different risk factor patterns for high‐grade and low‐grade intraepithelial lesions on the cervix among HPV‐positive and HPV‐negative young women , 1998, International journal of cancer.

[20]  D T Janerich,et al.  The screening histories of women with invasive cervical cancer, Connecticut. , 1995, American journal of public health.

[21]  A. Östör,et al.  Natural history of cervical intraepithelial neoplasia: a critical review. , 1993, International Journal of Gynecological Pathology.

[22]  C. la Vecchia,et al.  Screening practices and invasive cervical cancer risk in different age strata. , 1990, Gynecologic oncology.

[23]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.